India seeks vaccine loans from ADB, AIIB

Plan is to procure 667 million doses of COVID-19 vaccines.

October 27, 2021 08:33 pm | Updated October 28, 2021 10:02 am IST - HONG KONG

The Asian Development Bank is expected to lend $1.5 billion and the Asian Infrastructure Investment Bank around $500 million for the vaccine purchase by the Government of India

The Asian Development Bank is expected to lend $1.5 billion and the Asian Infrastructure Investment Bank around $500 million for the vaccine purchase by the Government of India

The Government of India has applied for loans from the Asian Development Bank (ADB) and the Asian Infrastructure Investment Bank (AIIB) to procure as many as 667 million doses of COVID-19 vaccines.

The Manila-based ADB, in which the U.S. and Japan are the biggest shareholders, and the Beijing-based AIIB, where China and India are the biggest shareholders, are in the process of considering the loans.

The ADB is expected to lend $1.5 billion and the AIIB around $500 million for the vaccine purchase by the Government of India, which has been made under the ADB’s Asia Pacific Vaccine Access Facility (APVAX) initiative.

Launched in December 2020, APVAX offers “rapid and equitable support to its developing member countries as they procure and deliver effective and safe COVID-19 vaccines”.

The 667 million doses will, however, have to be vaccines qualified by the World Health Organization (WHO). Covishield is among those vaccines, but Covaxin is still awaiting the green light with a final assessment scheduled for November 3.

According to the ADB, for a vaccine to be eligible for financing, it must “be procured via COVAX [the global vaccine access initiative], prequalified by WHO, or authorised by a Stringent Regulatory Authority”, which, according to the WHO, does not include India’s health authorities.

The Beijing-headquartered AIIB will co-finance the vaccine procurement. The bank said that this week, a number of loans were being considered for projects in India, including another loan for the next phase of the Chennai Metro rail system. Earlier this month, the AIIB had already approved a $356.7 million loan to the Government of India for the construction of a new corridor as part of Chennai Metro’s phase two.

So far, the AIIB has approved loans for 28 projects in India amounting to $6.7 billion, more than for any other member of the multilateral bank, which was launched in Beijing in 2015. India is the second-largest shareholder after China in the bank, which does not count the U.S. and Japan among its members.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.